Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00456378 · ClinicalTrials.gov registry record · NA

Study of the Safety and Effectiveness of DIAM™ Spinal Stabilization System Versus Conservative Care

A NA study, sponsored by Medtronic Spinal and Biologics.

Terminated
Registry status
NA
Development phase
311
Enrollment target

NCT00456378 is a NA study that was terminated before completion, run by Medtronic Spinal and Biologics. The registered enrollment target is 311 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00456378, a NA study, was terminated before completion, sponsored by Medtronic Spinal and Biologics.

TERMINATED
Registry status
NA
Development phase
311 participants
Enrollment target

Study Summary

The purpose of this study is to establish the safety and effectiveness of the DIAM™ Spinal Stabilization System in the treatment of moderate single-level lumbar degenerative disc disease.

Interventions

  • DEVICE DIAM™ Spinal Stabilization System
  • PROCEDURE Conservative care

Trial Details

FieldValue
Enrollment Target 311 participants
Start Date 2006-12
Est. Completion 2018-11-20
Phase NA

Sponsor

Medtronic Spinal and Biologics

26 total trials

What the Registry Record Tells You About NCT00456378

The ClinicalTrials.gov registry entry for NCT00456378 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 311 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Spinal and Biologics, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which DIAM™ Spinal Stabilization System is the first listed.

NCT00456378 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00456378 about?

NCT00456378 is a clinical study titled "Study of the Safety and Effectiveness of DIAM™ Spinal Stabilization System Versus Conservative Care". The purpose of this study is to establish the safety and effectiveness of the DIAM™ Spinal Stabilization System in the treatment of moderate single-level lumbar degenerative disc disease.

What is the current status of trial NCT00456378?

This trial is currently terminated. It is a NA study. The enrollment target is 311 participants. The study started on 2006-12. Estimated completion is 2018-11-20.

What interventions are being tested in trial NCT00456378?

The interventions under investigation include: DIAM™ Spinal Stabilization System (DEVICE), Conservative care (PROCEDURE).

Who is sponsoring clinical trial NCT00456378?

This trial is sponsored by Medtronic Spinal and Biologics, which has 26 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.